"Designing Growth Strategies is in our DNA"

Hereditary Angioedema Treatment Market Size, Share and Industry Analysis by Drug Class (C-1 Esterase Inhibitors, Bradykynin Receptor Antagonist, Kallikrein Inhibitors), By Application (Prophylaxis, Treatment), By Route of Administration (IV, Subcutaneous), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, others), and Regional Forecast 2018-2025

The global hereditary angioedema treatment market size was valued at USD 1,883.1 million in 2017 and is projected to reach USD 6,533.3 million by the end of 2025, exhibit... Read More

Final report will be updated to address the impact of COVID-19 on this particular market

Region : Global | Published Date: Apr, 2019 | Report ID: FBI100164 | Status : Published

 

Request Sample PDF

Refresh Button
Hereditary Angioedema Treatment Market Size, Share and Global Industry Trend Forecast till 2025
  • PDF
  • 2017
  • 2014-2016
  • 125
  • Direct Purchase
  • 4850
    6850
    8850

Healthcare Clients

DUPONT
Abbott
baxter
lpsos
Logo_Merck_KGaA_2015
chong-kun-dang
DAEWOONG
Natus-Medical
SUANFARMA
Bio-Rad
Intuitive_Surgical_logo
novo-nordisk
Ge-Healthcare
Sedana-Cyan-Black-Tag


We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X